We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+8.99%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.9B
AUM Growth
+$21.9B
(+100,205%)
Cap. Flow
-$417M
Cap. Flow
% of AUM
-1.9%
Top 10 Holdings %
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$89.3M |
| 2 |
Keysight
KEYS
|
+$86M |
| 3 |
Nike
NKE
|
+$78.3M |
| 4 |
Amphenol
APH
|
+$76.5M |
| 5 |
Comcast
CMCSA
|
+$72.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Celanese
CE
|
+$108M |
| 2 |
Monster Beverage
MNST
|
+$97.8M |
| 3 |
Starbucks
SBUX
|
+$79.7M |
| 4 |
Texas Instruments
TXN
|
+$67.3M |
| 5 |
Centene
CNC
|
+$64.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.83% |
| 2 | Financials | 13.42% |
| 3 | Healthcare | 13.25% |
| 4 | Industrials | 9.77% |
| 5 | Consumer Discretionary | 7.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Ambev
ABEV
$47.9B
| $20K | ﹤0.01% |
4,327
+2,021
| +88% | +$8.96K |
|
1702
Brown & Brown
BRO
$25.1B
| $20K | ﹤0.01% |
526
+255
| +94% | +$9.58K |
|
1703
Central Pacific Financial
CPF
$1.03B
| $20K | ﹤0.01% |
679
+156
| +30% | +$4.55K |
|
1704
The Ensign Group
ENSG
$10.5B
| $20K | ﹤0.01% |
474
+103
| +28% | +$4.35K |
|
1705
Ituran Location and Control
ITRN
$1.08B
| $20K | ﹤0.01% |
830
| – | – |
|
1706
Lloyds Banking Group
LYG
$85.8B
| $20K | ﹤0.01% |
6,236
-1,936
| -24% | -$5.86K |
|
|
NFBK
1707
DELISTED
Northfield Bancorp
NFBK
| $20K | ﹤0.01% |
1,230
+588
| +92% | +$9.87K |
|
1708
Enviri
NVRI
$637M
| $20K | ﹤0.01% |
891
+215
| +32% | +$4.49K |
|
1709
nVent Electric
NVT
$21.6B
| $20K | ﹤0.01% |
834
-90
| -10% | -$2.09K |
|
1710
Patrick Industries
PATK
$2.87B
| $20K | ﹤0.01% |
615
+105
| +21% | +$3.41K |
|
1711
Pearson
PSO
$10.6B
| $20K | ﹤0.01% |
2,379
+591
| +33% | +$5.08K |
|
1712
Patterson-UTI
PTEN
$3.6B
| $20K | ﹤0.01% |
2,017
-52
| -3% | -$471 |
|
1713
UMB Financial
UMBF
$11.2B
| $20K | ﹤0.01% |
300
-350
| -54% | -$23.2K |
|
1714
Vipshop
VIPS
$7.23B
| $20K | ﹤0.01% |
1,432
+336
| +31% | +$3.98K |
|
1715
Vanda Pharmaceuticals
VNDA
$301M
| $20K | ﹤0.01% |
1,236
+169
| +16% | +$2.56K |
|
1716
State Street Communication Services Select Sector SPDR ETF
XLC
$22.6B
| $20K | ﹤0.01% |
+381
| New | +$19.6K |
|
|
QVCGA
1717
DELISTED
QVC Group Inc Series A
QVCGA
| $20K | ﹤0.01% |
52
| – | – |
|
|
SYKE
1718
DELISTED
SYKES Enterprises Inc
SYKE
| $20K | ﹤0.01% |
546
+128
| +31% | +$4.33K |
|
|
GPOR
1719
DELISTED
Gulfport Energy Corp.
GPOR
| $20K | ﹤0.01% |
6,872
| – | – |
|
|
INAP
1720
DELISTED
Internap Corporation
INAP
| $20K | ﹤0.01% |
18,300
| – | – |
|
|
AHRT
1721
AH Realty Trust
AHRT
$540M
| $19K | ﹤0.01% |
1,042
+242
| +30% | +$4.39K |
|
|
AMRN
1722
Amarin Corp
AMRN
$302M
| $19K | ﹤0.01% |
45
-20
| -31% | -$7.6K |
|
1723
Astec Industries
ASTE
$1.18B
| $19K | ﹤0.01% |
468
+109
| +30% | +$3.96K |
|
1724
BJ's Restaurants
BJRI
$1.48B
| $19K | ﹤0.01% |
512
+75
| +17% | +$2.88K |
|
1725
Community Bank
CBU
$3.4B
| $19K | ﹤0.01% |
281
-49
| -15% | -$3.28K |
|
Similar funds
EWA
MIC
P
OSAM
CB
EIM
SC
Glenmede Trust's Q4 2019 Portfolio in Review
As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
- Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
- Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
- Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
- Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
- Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
- Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.
Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.